OSHA mandate is in direct violation of Federal law 21 USC 360bbb-3. All products, including masks, tests and Pfizer BionTech "vaccine" are still under EUA. Under EUA, you cannot mandate any of the above. While they did approve Comirnaty, which they say is the same, yet legally distinct from the EUA administered right now, Comirnaty is not available in the US.
Federal law 21 U.S.C. § 360bbb-3(e)(1)(A)(ii)(III) requires that the person to whom an EUA
vaccine is administered be advised, “of the option to accept or refuse administration of the
product, of the consequences, if any, of refusing administration of the product, and of the
alternatives to the product that are available and of their benefits and risks.” The reason for the
right of refusal stems from the fact that EUA products are by definition experimental. Even if the
FDA approves and licenses existing COVID vaccines, they will remain experimental and thus
subject to the international requirement that informed consent is “absolutely essential.”
Nuremberg Code, Article 1; Abdullahi v Pfizer, Inc., 562 F3d 163 [2d Cir 2009]. Phase III
clinical trials for the Pfizer vaccine do not end until May 2, 20231
; and for the Moderna vaccine
until October 27, 2022.2
OSHA mandate is in direct violation of Federal law 21 USC 360bbb-3. All products, including masks, tests and Pfizer BionTech "vaccine" are still under EUA. Under EUA, you cannot mandate any of the above. While they did approve Comirnaty, which they say is the same, yet legally distinct from the EUA administered right now, Comirnaty is not available in the US.
https://www.fda.gov/media/137121/download -- Face mask EUA https://www.fda.gov/media/136598/download -- PCR EUA https://www.fda.gov/media/136598/download ---- all separate PCR EUA
Federal law 21 U.S.C. § 360bbb-3(e)(1)(A)(ii)(III) requires that the person to whom an EUA vaccine is administered be advised, “of the option to accept or refuse administration of the product, of the consequences, if any, of refusing administration of the product, and of the alternatives to the product that are available and of their benefits and risks.” The reason for the right of refusal stems from the fact that EUA products are by definition experimental. Even if the FDA approves and licenses existing COVID vaccines, they will remain experimental and thus subject to the international requirement that informed consent is “absolutely essential.” Nuremberg Code, Article 1; Abdullahi v Pfizer, Inc., 562 F3d 163 [2d Cir 2009]. Phase III clinical trials for the Pfizer vaccine do not end until May 2, 20231 ; and for the Moderna vaccine until October 27, 2022.2